Praxis Precision Medicines to Participate in Goldmans Sachs 47th Annual Global Healthcare Conference

About this update from Praxis Precision Medicines, Inc.

BOSTON , June 04, 2026 (GLOBE NEWSWIRE) -- Praxis Precision Medicines , Inc. (NASDAQ: PRAX ), a fully integrated, leading central nervous system (CNS) precision neuroscience biopharmaceutical company, today announced it will be presenting a corporate overview at the Goldman Sachs 47th Annual Global Healthcare Conference 2026 taking place in Miami, FL at the Loews Miami Beach Hotel on Monday, June 8, 2026 at 8:00am ET . A live webcast of the event will be available through this link . A replay of the event will also be available on Praxis’ “ Events and Presentations ” website after each event for approximately 180 days. About Praxis Praxis Precision Medicines is a fully integrated, leading central nervous system (CNS) precision neuroscience biopharmaceutical company, translating insights from genetic epilepsies into the development of therapies for CNS disorders characterized by neuronal excitation-inhibition imbalance. Praxis is applying genetic insights to the discovery and development of therapies for rare and more prevalent neurological disorders through our proprietary small molecule platform, Cerebrum™, and antisense oligonucleotide (ASO) platform, Solidus™, using our understanding of shared biological targets and circuits in the brain. Praxis has established a diversified, multimodal CNS portfolio including multiple programs across movement disorders and epilepsy, with four late-stage product candidates. For more information, please visit www.praxismedicines.com and follow us on Facebook , LinkedIn and X/Twitter . Investor Contact: Praxis Precision Medicines [email protected] 857-702-9452 Media Contact: Dan Ferry LifeSci Advisors [email protected] 617-430-7576 Source: Praxis Precision Medicines, Inc.

View stock analysis, news, and events for Praxis Precision Medicines, Inc.